Understanding Analyst Reactions
Exciting news for investors as Summit Materials Inc (Symbol: SUM) emerges victorious, surpassing the average analyst 12-month target price of $43.31, currently trading at $43.92/share. A pivotal moment for analysts who now face the task of recalibrating their predictions — do they lower expectations based on valuation or adjust the target price upwards due to promising business developments that propel stock prices?
Within the Zacks coverage universe, Summit Materials Inc draws from 13 diverse analyst targets to formulate its average. However, beneath the surface of this mathematical calculation lie intriguing variations. While the mean stands at $43.31, individual analysts project lower figures such as $31.00, while one forecasts a loftier target of $50.00, with a notable standard deviation of $5.266.
Interpreting the Average
Why focus on the average SUM price target? This approach taps into the fabled “wisdom of crowds,” amalgamating the contributions of multiple minds to yield a single figure. Thus, SUM breaching the $43.31/share threshold signals to investors a prime opportunity for reassessment. Is $43.31 a mere stepping stone towards a higher target, or has valuation peaked, warranting a strategic shift? The analysts’ perspectives on Summit Materials Inc are summarized below:
Recent SUM Analyst Ratings Breakdown | ||||
---|---|---|---|---|
» | Current | 1 Month Ago | 2 Month Ago | 3 Month Ago |
Strong buy ratings: | 8 | 7 | 7 | 7 |
Buy ratings: | 0 | 0 | 1 | 1 |
Hold ratings: | 6 | 6 | 5 | 5 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.86 | 1.92 | 1.85 | 1.85 |
Analysts rate stocks on a scale of 5, ranging from Strong Buy (1) to Strong Sell (5). This data was sourced from Zacks Investment Research via Quandl.com. Stay informed with the latest Zacks research report on SUM, available for free.
Discover the top 10 ETFs with the most potential for growth according to analysts’ targets.
Further Exploration
For additional insights and analysis:
Monitor CVSI insider buying trends.
Review the history of LKCO’s outstanding shares.
Explore RBBN’s market cap history.
The perspectives shared are the author’s own and not necessarily reflective of Nasdaq, Inc.